TY - JOUR AU - Vesely, M. AU - Kershaw, M. AU - Schreiber, R. AU - Smyth, M. PY - 2011 DA - 2011// TI - Natural innate and adaptive immunity to cancer JO - Annu Rev Immunol VL - 29 UR - https://doi.org/10.1146/annurev-immunol-031210-101324 DO - 10.1146/annurev-immunol-031210-101324 ID - Vesely2011 ER - TY - JOUR AU - Rosenberg, S. A. AU - Yang, J. C. AU - Restifo, N. P. PY - 2004 DA - 2004// TI - Cancer immunotherapy: moving beyond current vaccines JO - Nat Med VL - 10 UR - https://doi.org/10.1038/nm1100 DO - 10.1038/nm1100 ID - Rosenberg2004 ER - TY - JOUR AU - Jochems, C. AU - Schlom, J. PY - 2011 DA - 2011// TI - Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity JO - Exp Biol Med VL - 236 UR - https://doi.org/10.1258/ebm.2011.011007 DO - 10.1258/ebm.2011.011007 ID - Jochems2011 ER - TY - JOUR AU - de Visser, K. E. AU - Eichten, A. AU - Coussens, L. M. PY - 2006 DA - 2006// TI - Paradoxical roles of the immune system during cancer development JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1782 DO - 10.1038/nrc1782 ID - de Visser2006 ER - TY - JOUR AU - Sica, A. AU - Larghi, P. AU - Mancino, A. AU - Rubino, L. AU - Porta, C. AU - Totaro, M. G. AU - Rimoldi, M. AU - Biswas, S. K. AU - Allavena, P. AU - Mantovani, A. PY - 2008 DA - 2008// TI - Macrophage polarization in tumour progression JO - Sem Cancer Biol VL - 18 UR - https://doi.org/10.1016/j.semcancer.2008.03.004 DO - 10.1016/j.semcancer.2008.03.004 ID - Sica2008 ER - TY - JOUR AU - Sakaguchi, S. AU - Sakaguchi, N. AU - Asano, M. AU - Itoh, M. M. T. PY - 1995 DA - 1995// TI - Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases JO - J Immunol VL - 155 ID - Sakaguchi1995 ER - TY - JOUR AU - Nishikawa, H. AU - Sakaguchi, S. PY - 2010 DA - 2010// TI - Regulatory T cells in tumor immunity JO - Int J Cancer VL - 127 ID - Nishikawa2010 ER - TY - JOUR AU - Mantovani, A. AU - Sica, A. PY - 2010 DA - 2010// TI - Macrophages, innate immunity and cancer: balance, tolerance, and diversity JO - Curr Opin Immunol VL - 22 UR - https://doi.org/10.1016/j.coi.2010.01.009 DO - 10.1016/j.coi.2010.01.009 ID - Mantovani2010 ER - TY - JOUR AU - Ruffell, B. AU - DeNardo, D. G. AU - Affara, N. I. AU - Coussens, L. M. PY - 2010 DA - 2010// TI - Lymphocytes in cancer development: polarization towards pro-tumor immunity JO - Cytokine Growth Factor Rev VL - 21 UR - https://doi.org/10.1016/j.cytogfr.2009.11.002 DO - 10.1016/j.cytogfr.2009.11.002 ID - Ruffell2010 ER - TY - JOUR AU - Hui, K. AU - Grosveld, F. AU - Festenstein, H. PY - 1984 DA - 1984// TI - Rejection of transplantable AKR leukemia cells following DNA-mediated cell transformation JO - Nature VL - 311 UR - https://doi.org/10.1038/311750a0 DO - 10.1038/311750a0 ID - Hui1984 ER - TY - JOUR AU - De Plaen, E. AU - Lurquin, C. AU - Lethe, B. AU - van der Bruggen, P. AU - Brichard, V. AU - Renauld, J. C. AU - Coulie, P. AU - Van Pel, A. AU - Boon, T. PY - 1997 DA - 1997// TI - Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes JO - Methods VL - 12 UR - https://doi.org/10.1006/meth.1997.0462 DO - 10.1006/meth.1997.0462 ID - De Plaen1997 ER - TY - JOUR AU - Rosenberg, S. A. AU - Restifo, N. P. AU - Yang, J. C. AU - Morgan, R. A. AU - Dudley, M. E. PY - 2008 DA - 2008// TI - Adoptive cell therapy: a clinical path to effective cancer immunotherapy JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2355 DO - 10.1038/nrc2355 ID - Rosenberg2008 ER - TY - JOUR AU - Kageshita, T. AU - Hirai, S. AU - Ono, T. AU - Hicklin, D. J. AU - Ferrone, S. PY - 1999 DA - 1999// TI - Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression JO - Am J Pathol VL - 154 UR - https://doi.org/10.1016/S0002-9440(10)65321-7 DO - 10.1016/S0002-9440(10)65321-7 ID - Kageshita1999 ER - TY - JOUR AU - Garcia-Lora, A. AU - Algarra, I. AU - Garrido, F. PY - 2003 DA - 2003// TI - MHC class I antigens, immune surveillance, and tumor immune escape JO - J Cell Physiol VL - 195 UR - https://doi.org/10.1002/jcp.10290 DO - 10.1002/jcp.10290 ID - Garcia-Lora2003 ER - TY - JOUR AU - Garrido, F. AU - Algarra, I. AU - García-Lora, A. M. PY - 2010 DA - 2010// TI - The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions JO - Cancer Immunol Immunother VL - 59 UR - https://doi.org/10.1007/s00262-010-0893-2 DO - 10.1007/s00262-010-0893-2 ID - Garrido2010 ER - TY - JOUR AU - Ossendorp, F. AU - Mengede, E. AU - Camps, M. AU - Filius, R. AU - Melief, C. J. PY - 1998 DA - 1998// TI - Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors JO - J Exp Med VL - 187 UR - https://doi.org/10.1084/jem.187.5.693 DO - 10.1084/jem.187.5.693 ID - Ossendorp1998 ER - TY - JOUR AU - Pardoll, D. M. AU - Topalian, S. L. PY - 1998 DA - 1998// TI - The role of CD4+ T cell responses in anti-tumor immunity JO - Curr Opin Immunol VL - 10 UR - https://doi.org/10.1016/S0952-7915(98)80228-8 DO - 10.1016/S0952-7915(98)80228-8 ID - Pardoll1998 ER - TY - JOUR AU - Hung, K. AU - Hayashi, R. AU - Lafond-Walker, A. AU - Lowenstein, C. AU - Pardoll, D. M. AU - Levitsky, H. PY - 1998 DA - 1998// TI - The central role of CD4+ T cells in the antitumor immune response JO - J Exp Med VL - 188 UR - https://doi.org/10.1084/jem.188.12.2357 DO - 10.1084/jem.188.12.2357 ID - Hung1998 ER - TY - JOUR AU - Germain, R. N. AU - Margulies, D. H. PY - 1993 DA - 1993// TI - The biochemistry and cellular biology of antigen processing and presentation JO - Annu Rev Immunol VL - 11 UR - https://doi.org/10.1146/annurev.iy.11.040193.002155 DO - 10.1146/annurev.iy.11.040193.002155 ID - Germain1993 ER - TY - JOUR AU - Mitchison, N. A. PY - 1964 DA - 1964// TI - Induction of immunological paralysis in two zones of dosage JO - Proc R Soc Lond VL - 161 UR - https://doi.org/10.1098/rspb.1964.0093 DO - 10.1098/rspb.1964.0093 ID - Mitchison1964 ER - TY - JOUR AU - Makela, O. AU - Mitchison, N. A. PY - 1965 DA - 1965// TI - The effect of antigen dosage on the response of adoptively transferred cells JO - Immunology VL - 8 ID - Makela1965 ER - TY - JOUR AU - Zinkernagel, R. M. AU - Ehl, S. AU - Aichele, P. AU - Oehen, S. AU - Kundig, T. M. AU - Hengartner, H. PY - 1997 DA - 1997// TI - Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity JO - Immunol Rev VL - 156 UR - https://doi.org/10.1111/j.1600-065X.1997.tb00969.x DO - 10.1111/j.1600-065X.1997.tb00969.x ID - Zinkernagel1997 ER - TY - JOUR AU - Dranoff, G. PY - 2004 DA - 2004// TI - Cytokines in cancer pathogenesis and cancer therapy JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1252 DO - 10.1038/nrc1252 ID - Dranoff2004 ER - TY - JOUR AU - Accolla, R. S. AU - Jotterand-Bellomo, M. AU - Scarpellino, L. AU - Maffei, A. AU - Carra, G. AU - Guardiola, J. PY - 1986 DA - 1986// TI - Air-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression JO - J Exp Med VL - 164 UR - https://doi.org/10.1084/jem.164.1.369 DO - 10.1084/jem.164.1.369 ID - Accolla1986 ER - TY - JOUR AU - Steimle, V. AU - Otten, L. A. AU - Zufferey, M. AU - Mach, B. PY - 1993 DA - 1993// TI - Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome) JO - Cell VL - 75 UR - https://doi.org/10.1016/S0092-8674(05)80090-X DO - 10.1016/S0092-8674(05)80090-X ID - Steimle1993 ER - TY - JOUR AU - Meazza, R. AU - Comes, A. AU - Orengo, A. M. AU - Ferrini, S. AU - Accolla, R. S. PY - 2003 DA - 2003// TI - Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells JO - Eur J Immunol VL - 33 UR - https://doi.org/10.1002/eji.200323712 DO - 10.1002/eji.200323712 ID - Meazza2003 ER - TY - JOUR AU - Harton, J. A. AU - Ting, J. P. Y. PY - 2000 DA - 2000// TI - Class II transactivator: mastering the art of major histocompatibility complex expression JO - Mol Cell Biol VL - 20 UR - https://doi.org/10.1128/MCB.20.17.6185-6194.2000 DO - 10.1128/MCB.20.17.6185-6194.2000 ID - Harton2000 ER - TY - JOUR AU - Rudensky, A. AU - Preston-Hurlburt, P. AU - Hong, S. C. AU - Barlow, A. AU - Janeway, C. A. J. PY - 1991 DA - 1991// TI - Sequence analysis of peptides bound to MHC class II molecules JO - Nature VL - 353 UR - https://doi.org/10.1038/353622a0 DO - 10.1038/353622a0 ID - Rudensky1991 ER - TY - JOUR AU - Schimd, D. AU - Pypaert, M. AU - Munz, C. PY - 2007 DA - 2007// TI - Antigen-loading compartments for major histocompatibility class II molecules continuously receive input from autophagosomes JO - Immunity VL - 26 UR - https://doi.org/10.1016/j.immuni.2006.10.018 DO - 10.1016/j.immuni.2006.10.018 ID - Schimd2007 ER - TY - JOUR AU - Chicz, R. M. AU - Urban, R. G. AU - Gorga, J. C. AU - Vignali, D. A. AU - Lane, W. S. AU - Strominger, J. L. PY - 1993 DA - 1993// TI - Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles JO - J Exp Med VL - 178 UR - https://doi.org/10.1084/jem.178.1.27 DO - 10.1084/jem.178.1.27 ID - Chicz1993 ER - TY - JOUR AU - Jaraquemada, D. AU - Marti, M. AU - Long, E. O. PY - 1990 DA - 1990// TI - An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytosolic antigens to MHC class II-restricted T cells JO - J Exp Med VL - 172 UR - https://doi.org/10.1084/jem.172.3.947 DO - 10.1084/jem.172.3.947 ID - Jaraquemada1990 ER - TY - JOUR AU - Mortara, L. AU - Castellani, P. AU - Meazza, R. AU - Tosi, G. AU - De Lerma Barbaro, A. AU - Procopio, F. A. AU - Comes, A. AU - Zardi, L. AU - Ferrini, S. AU - Accolla, R. S. PY - 2006 DA - 2006// TI - CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0165 DO - 10.1158/1078-0432.CCR-06-0165 ID - Mortara2006 ER - TY - JOUR AU - Frangione, V. AU - Mortara, L. AU - Castellani, P. AU - De Lerma Barbaro, A. AU - Accolla, R. S. PY - 2010 DA - 2010// TI - CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy JO - Int J Cancer VL - 127 UR - https://doi.org/10.1002/ijc.25183 DO - 10.1002/ijc.25183 ID - Frangione2010 ER - TY - JOUR AU - Mortara, L. AU - Frangione, V. AU - Castellani, P. AU - De Lerma Barbaro, A. AU - Accolla, R. S. PY - 2009 DA - 2009// TI - Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions JO - Int Immunol VL - 21 UR - https://doi.org/10.1093/intimm/dxp034 DO - 10.1093/intimm/dxp034 ID - Mortara2009 ER - TY - JOUR AU - Sartoris, S. AU - Valle, M. T. AU - De Lerma Barbaro, A. AU - Tosi, G. AU - Cestari, T. AU - D’Agostino, A. M. M. A. AU - Manca, F. AU - Accolla, R. S. PY - 1998 DA - 1998// TI - HLA class II expression in uninducible hepatocarcinoma cells after trasfection of the AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity JO - J Immunol VL - 161 ID - Sartoris1998 ER - TY - JOUR AU - Armstrong, T. AU - Clements, V. AU - Ostrand-Rosenberg, S. PY - 1998 DA - 1998// TI - MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes JO - J Immunol VL - 160 ID - Armstrong1998 ER - TY - JOUR AU - Qi, L. AU - Rojas, J. AU - Ostrand-Rosenberg, S. PY - 2000 DA - 2000// TI - Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo JO - J Immunol VL - 165 UR - https://doi.org/10.4049/jimmunol.165.10.5451 DO - 10.4049/jimmunol.165.10.5451 ID - Qi2000 ER - TY - JOUR AU - Dissanayake, S. AU - Tuera, N. AU - Ostrand-Rosenberg, S. PY - 2005 DA - 2005// TI - Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome JO - J Immunol VL - 174 UR - https://doi.org/10.4049/jimmunol.174.4.1811 DO - 10.4049/jimmunol.174.4.1811 ID - Dissanayake2005 ER - TY - JOUR AU - Bonehill, A. AU - Heirman, C. AU - Tuyaerts, S. AU - Michiels, A. AU - Zhang, Y. AU - van der Bruggen, P. AU - Thielemans, K. PY - 2003 DA - 2003// TI - Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an Invariant chain with genetic exchange of class II-associated Invariant Chain Peptide JO - Cancer Res VL - 63 ID - Bonehill2003 ER - TY - JOUR AU - Brulet, J. -. M. AU - Maudoux, F. AU - Thomas, S. AU - Thielemans, K. AU - Burny, A. AU - Leo, O. AU - Bex, F. AU - Hallez, S. PY - 2007 DA - 2007// TI - DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T celldependent protection JO - Eur J Immunol VL - 37 UR - https://doi.org/10.1002/eji.200636233 DO - 10.1002/eji.200636233 ID - Brulet2007 ER - TY - JOUR AU - Mittendorf, E. A. AU - Holmes, J. P. AU - Murray, J. L. AU - von Hofe, E. AU - Peoples, G. E. PY - 2009 DA - 2009// TI - CD4+ T cells in antitumor immunity: utility of an li-key HER2/neu hybrid peptide vaccine (AE37) JO - Expert Opin Biol Ther VL - 9 UR - https://doi.org/10.1517/14712590802614538 DO - 10.1517/14712590802614538 ID - Mittendorf2009 ER - TY - JOUR AU - Atanackovic, D. AU - Luetkens, T. AU - Kloth, B. AU - Fuchs, G. AU - Cao, Y. AU - Hildebrandt, Y. AU - Meyer, S. AU - Bartels, K. AU - Reinhard, H. AU - Lajmi, N. PY - 2011 DA - 2011// TI - Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia JO - Am J Hematol VL - 86 UR - https://doi.org/10.1002/ajh.22141 DO - 10.1002/ajh.22141 ID - Atanackovic2011 ER - TY - JOUR AU - Claus, R. AU - Almstedt, M. AU - Lubbert, M. PY - 2005 DA - 2005// TI - Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents JO - Semin Oncol VL - 32 UR - https://doi.org/10.1053/j.seminoncol.2005.07.024 DO - 10.1053/j.seminoncol.2005.07.024 ID - Claus2005 ER - TY - JOUR AU - Borsi, L. AU - Balza, E. AU - Carnemolla, B. AU - Sassi, F. AU - Castellani, P. AU - Berndt, A. AU - Kosmehl, H. AU - Biro, A. AU - Siri, A. AU - Orecchia, P. PY - 2003 DA - 2003// TI - Selective targeted delivery of TNFalpha to tumor blood vessels JO - Blood VL - 102 UR - https://doi.org/10.1182/blood-2003-04-1039 DO - 10.1182/blood-2003-04-1039 ID - Borsi2003 ER - TY - JOUR AU - Balza, E. AU - Mortara, L. AU - Sassi, F. AU - Monteghirfo, S. AU - Carnemolla, B. AU - Castellani, P. AU - Neri, D. AU - Accolla, R. S. AU - Zardi, L. AU - Borsi, L. PY - 2006 DA - 2006// TI - Targeted delivery of tumor necrosis factor-a to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-2448 DO - 10.1158/1078-0432.CCR-05-2448 ID - Balza2006 ER - TY - JOUR AU - Mortara, L. AU - Balza, E. AU - Sassi, F. AU - Castellani, P. AU - Carnemolla, B. AU - De Lerma Barbaro, A. AU - Fossati, S. AU - Tosi, G. AU - Accolla, R. S. AU - Borsi, L. PY - 2007 DA - 2007// TI - Therapy-induced antitumor vaccination by targeting tumor necrosis factor-a to tumor vessels in combination with melphalan JO - Eur J Immunol VL - 37 UR - https://doi.org/10.1002/eji.200737450 DO - 10.1002/eji.200737450 ID - Mortara2007 ER - TY - JOUR AU - Balza, E. AU - Carnemolla, B. AU - Mortara, L. AU - Castellani, P. AU - Soncini, D. AU - Accolla, R. S. AU - Borsi, L. PY - 2010 DA - 2010// TI - Therapy-induced antitumor vaccination in neuroblastomas by the combined targeting of IL-2 and TNFalpha JO - Int J Cancer VL - 127 UR - https://doi.org/10.1002/ijc.25018 DO - 10.1002/ijc.25018 ID - Balza2010 ER - TY - JOUR AU - Takeshima, T. AU - Chamoto, K. AU - Wakita, D. AU - Ohkuri, T. AU - Togashi, Y. AU - Shirato, H. AU - Kitamura, H. AU - Nishimura, T. PY - 2010 DA - 2010// TI - Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-2982 DO - 10.1158/0008-5472.CAN-09-2982 ID - Takeshima2010 ER - TY - JOUR AU - Lee, J. AU - Moran, J. P. AU - Fenton, B. M. AU - Koch, C. J. AU - Frelinger, J. G. AU - Keng, P. C. AU - Lord, E. M. PY - 2000 DA - 2000// TI - Alteration of tumour response to radiation by interleukin-2 gene transfer JO - Br J Cancer VL - 82 UR - https://doi.org/10.1054/bjoc.1999.1022 DO - 10.1054/bjoc.1999.1022 ID - Lee2000 ER - TY - JOUR AU - Yamini, B. AU - Yu, X. AU - Pytel, P. AU - Galanopoulos, N. AU - Rawlani, V. AU - Veerapong, J. AU - Bickenbach, K. AU - Weichselbaum, R. R. PY - 2007 DA - 2007// TI - Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-1421 DO - 10.1158/1078-0432.CCR-07-1421 ID - Yamini2007 ER - TY - JOUR AU - Lugade, A. A. AU - Moran, J. P. AU - Gerber, S. A. AU - Rose, R. C. AU - Frelinger, J. G. AU - Lord, E. M. PY - 2005 DA - 2005// TI - Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor JO - J Immunol VL - 174 UR - https://doi.org/10.4049/jimmunol.174.12.7516 DO - 10.4049/jimmunol.174.12.7516 ID - Lugade2005 ER - TY - JOUR AU - Reits, E. A. AU - Hodge, J. W. AU - Herberts, C. A. AU - Groothuis, T. A. AU - Chakraborty, M. AU - Wansley, E. K. AU - Camphausen, K. AU - Luiten, R. M. AU - de Ru, A. H. AU - Neijssen, J. PY - 2006 DA - 2006// TI - Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy JO - J Exp Med VL - 203 UR - https://doi.org/10.1084/jem.20052494 DO - 10.1084/jem.20052494 ID - Reits2006 ER - TY - JOUR AU - Liao, Y. P. AU - Wang, C. C. AU - Butterfield, L. H. AU - Economou, J. S. AU - Ribas, A. AU - Meng, W. S. AU - Iwamoto, K. S. AU - McBride, W. H. PY - 2004 DA - 2004// TI - Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells JO - J Immunol VL - 173 UR - https://doi.org/10.4049/jimmunol.173.4.2462 DO - 10.4049/jimmunol.173.4.2462 ID - Liao2004 ER - TY - JOUR AU - Zitvogel, L. AU - Kepp, O. AU - Kroemer, G. PY - 2011 DA - 2011// TI - Immune parameters affecting the efficacy of chemotherapeutic regimens JO - Nat Rev Clin Oncol VL - 8 UR - https://doi.org/10.1038/nrclinonc.2010.223 DO - 10.1038/nrclinonc.2010.223 ID - Zitvogel2011 ER - TY - JOUR AU - Lake, R. A. AU - Robinson, B. W. S. PY - 2005 DA - 2005// TI - Immunotherapy and chemotherapy- a practical partnership JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1613 DO - 10.1038/nrc1613 ID - Lake2005 ER -